产品说明书

Rabeprazole Sodium Salt

Print
Chemical Structure| 117976-90-6 同义名 : 雷贝拉唑钠盐 ;LY307640 sodium;Rabeprazole (sodium salt);dexrabeprazole;3810, E;Rebeprazole sodium;Aciphex;Pariet;LY307640;E 3810;Habeprazole Sodium;Dexrabeprazole Sodium;Aciphex Sodium;Rabeprazole sodium
CAS号 : 117976-90-6
货号 : A101729
分子式 : C18H20N3NaO3S
纯度 : 98%
分子量 : 381.425
MDL号 : MFCD02092688
存储条件:

粉末 Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(275.28 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 65 mg/mL(170.41 mM),配合低频超声,并调节pH至11

动物实验配方:
生物活性
描述 Rabeprazole sodium acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM[3]. Rabeprazole is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity used in the therapy of gastroesophageal reflux and peptic ulcer disease[4]. Rabeprazole can attenuate the cell viability of human gastric cancer cells through inactivation of the ERK1/2 (extracellular signal-regulated protein kinase 1/2) signaling pathway[5]. Femurs from mice received rabeprazole showed widely separated, thin-walled bone trabeculae and increased number of osteoclasts[6]. In human studies, once-daily doses of 5-40 mg of rabeprazole inhibit gastric acid secretion in a dose-dependent fashion[7].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00234117 Bronchial Asthma ... 展开 >> Gastroesophageal Reflux 收起 << Not Applicable Completed - Puerto Rico ... 展开 >> Ponce Gastroentrology Research Ponce, Puerto Rico, 00717 收起 <<
NCT01237353 Pharmacodynamic Not Applicable Completed - United States, California ... 展开 >> University of California San Francisco San Francisco, California, United States, 94143 收起 <<
NCT01237353 - Completed - -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.62mL

0.52mL

0.26mL

13.11mL

2.62mL

1.31mL

26.22mL

5.24mL

2.62mL

参考文献

[1]Yamasaki Y, et al. Biomed Rep. 2016, 5(1):118-124.

[2]Gu M, et al. Oncol Lett. 2014, 8(4):1739-1744.

[3]Shea TA, Burburan PJ, Matubia VN, Ramcharan SS, Rosario I Jr, Parkin DW, Stockman BJ. Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase. Bioorg Med Chem Lett. 2014 Feb 15;24(4):1080-4

[4]LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. Rabeprazole. 2019 Apr 15

[5]Gu M, Zhang Y, Zhou X, Ma H, Yao H, Ji F. Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines. Oncol Lett. 2014 Oct;8(4):1739-1744

[6]Shaalan AAM, El-Sherbiny M, El-Abaseri TB, Shoaeir MZ, Abdel-Aziz TM, Mohamed MI, Zaitone SA, Mohammad HMF. Supplement With Calcium or Alendronate Suppresses Osteopenia Due to Long Term Rabeprazole Treatment in Female Mice: Influence on Bone TRAP and Osteopontin Levels. Front Pharmacol. 2020 May 13;11:583

[7]Williams MP, Pounder RE. Review article: the pharmacology of rabeprazole. Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:3-10